Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest announcement is out from Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh ( (AU:RMD) ).
ResMed Inc., a company involved in the production and development of medical devices, particularly focusing on sleep-related respiratory care, has announced a change in the beneficial ownership by Peter C. Farrell, its Chairman Emeritus. The transaction involved the sale of 2,000 shares of ResMed common stock at a price of $242.11 per share, conducted under a pre-established Rule 10b5-1 trading plan, which may have implications on the company’s stock market position and investor sentiment.
More about Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh
YTD Price Performance: 5.96%
Average Trading Volume: 910,617
Technical Sentiment Consensus Rating: Sell
Current Market Cap: A$56.47B
See more data about RMD stock on TipRanks’ Stock Analysis page.